Taltobulin - CISMeF

Preferred Label : Taltobulin;

NCIt definition : An analogue of the naturally occurring tripeptide hemiasterlin, with potential antimitotic and antineoplastic activities. Taltobulin binds tubulin in a similar manner as colchicine and inhibits tubulin polymerization. This results in the disruption of the cytoskeleton, ultimately leading to cell cycle arrest in G2/M phase, blockage of cell division and apoptosis.;

UNII : J6D6912BXS;

InChIKey : CNTMOLDWXSVYKD-PSRNMDMQSA-N;

CAS number : 228266-40-8; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 228266-40-8 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : HTI-286; SPA-110;

Chemical formula : C27H43N3O4;

Details

Origin ID

C75998;

UMLS CUI

C1872680;

Automatic exact mappings (from CISMeF team)
- HTI-286 [MeSH Supplementary Concept]
Currated CISMeF NLP mapping
- taltobulin [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- taltobulin [MeSH concept]
chemical_or_drug_has_mechanism_of_action
- Microtubule Process [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients